Joseph A B
Acta Psychiatr Scand. 1987 Mar;75(3):330-2. doi: 10.1111/j.1600-0447.1987.tb02797.x.
A patient with chronic psychosis and intermittent psychotic misidentification of the Capgras and intermetamorphosis types refractory to neuroleptic treatment was given a trial of clorazepate. Complete remission of psychotic symptoms was achieved for the first time in 19 years, but these recurred when the patient discontinued her clorazepate. It is concluded that clorazepate may be a useful treatment for some cases of chronic psychosis and psychotic misidentification. A possible mechanism for this is discussed.
一名患有慢性精神病且对神经阻滞剂治疗无效的Capgras和变身妄想型间歇性精神病性身份识别障碍患者接受了氯氮䓬的试验。19年来首次实现了精神病症状的完全缓解，但在患者停用氯氮䓬后症状复发。得出的结论是，氯氮䓬可能对某些慢性精神病和精神病性身份识别障碍病例有用。并讨论了其可能的机制。
